Daisy M A E Jonkers
Overview
Explore the profile of Daisy M A E Jonkers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
3740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stevens C, Adriaans G, Spooren C, Peters V, Pierik M, Weersma R, et al.
Clin Nutr
. 2025 Mar;
47:212-226.
PMID: 40048994
Background & Aims: Diet is an important environmental factor in inflammatory bowel disease (IBD) onset and disease course, but analyses are hindered by its complexity. We aim to explore the...
2.
Demers K, Bongers B, van Kuijk S, Plasqui G, Jonkers D, Pierik M, et al.
Dig Dis Sci
. 2024 Oct;
69(11):4072-4088.
PMID: 39425857
Background: Monitoring health-related physical fitness (HRPF) may benefit proactive Inflammatory Bowel Disease (IBD) management. However, knowledge regarding HRPF in patients with IBD is limited and gold standard tests are impractical...
3.
An R, Wilms E, Gerritsen J, Kim H, Perez C, Besseling-van der Vaart I, et al.
Gut Microbes
. 2024 May;
16(1):2350173.
PMID: 38738780
Although fecal microbiota composition is considered to preserve relevant and representative information for distal colonic content, it is evident that it does not represent microbial communities inhabiting the small intestine....
4.
Demers K, Bongers B, Jonkers D, Pierik M, Stassen L
Trials
. 2024 May;
25(1):314.
PMID: 38730331
No abstract available.
5.
Aliu A, Bosch D, Keszthelyi D, Rezazadeh Ardabili A, Colombel J, Sawyer R, et al.
Aliment Pharmacol Ther
. 2024 May;
59(12):1646-1647.
PMID: 38726864
No abstract available.
6.
Aliu A, Bosch D, Keszthelyi D, Rezazadeh Ardabili A, Colombel J, Sawyer R, et al.
Aliment Pharmacol Ther
. 2024 Apr;
59(12):1470-1488.
PMID: 38590140
Background: Persistent gastrointestinal symptoms are prevalent in adult patients with inflammatory bowel disease (IBD), even when endoscopic remission is reached. These symptoms can have profound negative effects on the quality...
7.
de Graaf M, Keszthelyi D, Brouns F, Dye L, Jonkers D
Lancet Gastroenterol Hepatol
. 2024 Mar;
9(4):293-294.
PMID: 38460538
No abstract available.
8.
de Graaf M, Timmers E, Bonekamp B, van Rooy G, Witteman B, Shewry P, et al.
Am J Clin Nutr
. 2024 Feb;
119(4):896-907.
PMID: 38373694
Background: Many individuals reduce their bread intake because they believe wheat causes their gastrointestinal (GI) symptoms. Different wheat species and processing methods may affect these responses. Objectives: We investigated the...
9.
de Graaf M, Lawton C, Croden F, Smolinska A, Winkens B, Hesselink M, et al.
Lancet Gastroenterol Hepatol
. 2023 Dec;
9(2):110-123.
PMID: 38040019
Background: Many individuals without coeliac disease or wheat allergy reduce their gluten intake because they believe that gluten causes their gastrointestinal symptoms. Symptoms could be affected by negative expectancy. Therefore,...
10.
Demers K, Bak M, Bongers B, de Vries A, Jonkers D, Pierik M, et al.
World J Gastroenterol
. 2023 Oct;
29(38):5406-5427.
PMID: 37900583
Background: Reaching the Selecting Therapeutic Targets in Inflammatory Bowel Disease-II (STRIDE-II) therapeutic targets for inflammatory bowel disease (IBD) requires an interdisciplinary approach. Lifestyle interventions focusing on enhancing and preserving health-related...